MJ9 uptake was significantly higher in the prostate and lymph nodes than FCH uptake, while FCH uptake was significantly higher than MJ9 uptake in bone lesions, confirming the role of bombesin analogues in the initial staging of prostate cancer patients. This evidence concerns the gene GRP and Familial prostate cancer.